SLC38A7 and nervous system disorder: Since inhibitors of monoamine transporters have been widely used as antidepressants, amino acid transporters specific for monoamine neurotransmitter synthesis (such as TADR) may provide new treatment options for neurological diseases associated with the dysregulation of monoamine neurotransmitters (Andersen et al., 2009).